ZIOPHARM Oncology Inc (ZIOP)

7.04
NASDAQ : Health Care
Prev Close 7.51
Day Low/High 6.90 / 7.61
52 Wk Low/High 4.45 / 8.72
Avg Volume 1.33M
Exchange NASDAQ
Shares Outstanding 132.38M
Market Cap 994.15M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views

Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on whether Judgment Day is here for the financials and discusses General Electric, Apple and Caterpillar.

Intrexon, ZIOPHARM And Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered By Membrane-Bound IL-15 Under RheoSwitch Therapeutic System® Control

Intrexon, ZIOPHARM And Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered By Membrane-Bound IL-15 Under RheoSwitch Therapeutic System® Control

Two CAR Targets Selected Enable Range of Potential Therapeutic Candidates for Both Solid and Liquid Tumors

ZIOPHARM Appoints Amy Trevvett Vice President Of Investor Relations And Corporate Communications

ZIOPHARM Appoints Amy Trevvett Vice President Of Investor Relations And Corporate Communications

Company to Host Quarterly Conference Calls

Twitter, Netflix, MetLife: Doug Kass' Views

Twitter, Netflix, MetLife: Doug Kass' Views

Doug Kass shares his thoughts on Twitter and talks about Sears.

First Week of ZIOP May 19th Options Trading

First Week of ZIOP May 19th Options Trading

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

ZIOPHARM Oncology Breaks Below 200-Day Moving Average - Notable for ZIOP

ZIOPHARM Oncology Breaks Below 200-Day Moving Average - Notable for ZIOP

In trading on Tuesday, shares of ZIOPHARM Oncology Inc crossed below their 200 day moving average of $5.89, changing hands as low as $5.85 per share. ZIOPHARM Oncology Inc shares are currently trading off about 6.2% on the day.

Don't Overlook Ziopharm Oncology

Don't Overlook Ziopharm Oncology

The stock is poised for an upside breakout.

Biotechs Among 5 Stocks Setting Up for Major Breakouts

Biotechs Among 5 Stocks Setting Up for Major Breakouts

Here's how to rake in the profits off some potential big breakouts.

Interesting ZIOP Put And Call Options For October 20th

Interesting ZIOP Put And Call Options For October 20th

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the October 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ZIOP Makes Bullish Cross Above Critical Moving Average

ZIOP Makes Bullish Cross Above Critical Moving Average

In trading on Thursday, shares of ZIOPHARM Oncology Inc crossed above their 200 day moving average of $6.06, changing hands as high as $6.35 per share. ZIOPHARM Oncology Inc shares are currently trading up about 8.2% on the day.

Interesting ZIOP Put And Call Options For March 17th

Interesting ZIOP Put And Call Options For March 17th

Investors in ZIOPHARM Oncology Inc saw new options become available this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

Allergan, Apple, Facebook: Doug Kass' Views

Allergan, Apple, Facebook: Doug Kass' Views

Doug Kass shares his thoughts on buying retail, and discusses why he's favoring the short side in a big way.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Interesting ZIOP Put And Call Options For February 2017

Interesting ZIOP Put And Call Options For February 2017

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Facebook, Apple, Starbucks: Doug Kass' Views

Facebook, Apple, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on managing and selecting short-term trades.

First Week of July 2017 Options Trading For ZIOPHARM Oncology (ZIOP)

First Week of July 2017 Options Trading For ZIOPHARM Oncology (ZIOP)

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the July 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Bullish and Bearish Chart Reversals

What stocks have changed direction in the past week.

ZIOPHARM Reports Third Quarter 2016 Financial Results And Provides Update On Recent Activities

ZIOPHARM Reports Third Quarter 2016 Financial Results And Provides Update On Recent Activities

Company to Host Conference Call on Thursday, November 17, 2016 at 8:00 am ET to Discuss Updated Data from Phase 1 Study of Ad-RTS-hIL-12 + Veledimex in Brain Cancer Presented at SNO 2016 Annual Meeting